Tetracistronic minigenomes elucidate a functional promoter for Ghana virus and unveils Cedar virus replicase promiscuity for all henipaviruses.

Ghana virus Nipah virus antivirals emerging pathogens henipavirus high biocontainment minigenome paramyxovirus reverse genetics viral RNA dependent RNA polymerase

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
30 Sep 2024
Historique:
medline: 30 9 2024
pubmed: 30 9 2024
entrez: 30 9 2024
Statut: aheadofprint

Résumé

Batborne henipaviruses, such as Nipah and Hendra viruses, represent a major threat to global health due to their propensity for spillover, severe pathogenicity, and high mortality rate in human hosts. Coupled with the absence of approved vaccines or therapeutics, work with the prototypical species and uncharacterized, emergent species is restricted to high biocontainment facilities. There is a scarcity of such specialized spaces for research, and often, the scope and capacity of research, which can be conducted at BSL-4, is limited. Therefore, there is a pressing need for innovative life-cycle modeling systems to enable comprehensive research within lower biocontainment settings. This work showcases tetracistronic, transcription, and replication-competent minigenomes for the Nipah, Hendra, and Cedar viruses, which encode viral proteins facilitating budding, fusion, and receptor binding. We validate the functionality of all encoded viral proteins and demonstrate a variety of applications to interrogate the viral life cycle. Notably, we found that the Cedar virus replicase exhibits remarkable promiscuity, efficiently driving replication and transcription of minigenomes from all tested henipaviruses. We also apply this technology to Ghana virus (GhV), an emergent species that has so far not been isolated in culture. We demonstrate that the reported sequence of GhV is incomplete, but that this missing sequence can be substituted with analogous sequences from other henipaviruses. The use of our GhV system establishes the functionality of the GhV replicase and identifies two antivirals that are highly efficacious against the GhV polymerase. Henipaviruses are recognized as significant global health threats due to their high mortality rates and lack of effective vaccines or therapeutics. Due to the requirement for high biocontainment facilities, the scope of research which may be conducted on henipaviruses is limited. To address this challenge, we developed innovative tetracistronic, transcription, and replication-competent minigenomes. We demonstrate that these systems replicate key aspects of the viral life cycle, such as budding, fusion, and receptor binding, and are safe for use in lower biocontainment settings. Importantly, the application of this system to the Ghana virus revealed that its known sequence is incomplete; however, substituting the missing sequences with those from other henipaviruses allowed us to overcome this challenge. We demonstrate that the Ghana virus replicative machinery is functional and can identify two orally efficacious antivirals effective against it. Our research offers a versatile system for life-cycle modeling of highly pathogenic henipaviruses at low biocontainment.

Identifiants

pubmed: 39345144
doi: 10.1128/jvi.00806-24
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0080624

Auteurs

Griffin D Haas (GD)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Shreyas Kowdle (S)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Katharina S Schmitz (KS)

Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.

Kristopher D Azarm (KD)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Kendra N Johnson (KN)

Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.

William R Klain (WR)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Alexander N Freiberg (AN)

Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.

Robert M Cox (RM)

Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.

Richard K Plemper (RK)

Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.

Benhur Lee (B)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Classifications MeSH